Gate Bioscience

Brisbane, CA · Founded 2021 · Privately Held (backing)

Developer of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease. Gate Bioscience is based in Brisbane, CA and was founded in 2021. Its last reported valuation was $161 million in Nov 2025. It has raised $135 million.

Last reported valuation
$161.0M
Oct 2026
Priced at
—
Total raised
$134.5M
Last round
—

Who backs Gate Bioscience?

6 investors
InvestorType
Andreessen HorowitzVenture capital
GVVenture capital
ARCH Venture PartnersVenture capital
ForbionVenture capital
Versant VenturesVenture capital
Eli Lilly—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Gate Bioscience investors

6 investors are on record for Gate Bioscience, including Andreessen Horowitz, GV, ARCH Venture Partners and Forbion. By type, the record holds 5 venture capital firms.

Free account
More of Gate Bioscience with a free account
  • ·Watch Gate Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Gate Bioscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View